On September 22, 2025, MBX Biosciences announced positive topline results from its Phase 2 Avail trial, with once-weekly canvuparatide achieving the primary endpoint with statistical significance and ...

Earlier this year, Coca-Cola raised its quarterly dividend for the 63rd consecutive year, reaffirming its position as a ...

If you’re like me, you love the idea of cryptocurrency ETFs, but not because you can explain terms like blockchain, ...

Automation offers a way to address two interconnected challenges for Western manufacturers—lackluster productivity growth and ...